Todsaporn Nakarat
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Todsaporn Nakarat has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Annerose Keilmann
Section of Communication Disorders, Clinic of Otorhinolaryngology, Head and Neck Surgery, University of Mainz Mainz, Germany
1 shared publication - David Molter
Department of Otolaryngology Washington University School of Medicine St. Louis MO USA
1 shared publication - Gunilla Malm
19Department of Pediatrics, Karolinska Institute, Stockholm, Sweden
1 shared publication - Iain Alexander Bruce
Department of Paediatric Otolaryngology, Royal Manchester Children’s Hospital, Manchester Foundation Trust, Manchester, UK; Division of Immunology, Immunity to Infection and Respiratory Medicine, University of Manchester, Faculty of Biology, Medicine & Health, Manchester, UK
1 shared publication on behalf of the HOS Investigators
1 shared publication
Latest Publications
- 25 August 2011
- Published by Wiley in Journal of Inherited Metabolic Disease
- Vol. 35 (2) , 343-353
Hearing loss in patients with mucopolysaccharidosis II: Data from HOS – the Hunter Outcome Survey
Background: Subjectively reported hearing loss is a common feature of mucopolysaccharidosis II (MPS II, Hunter syndrome). This study provides an epidemiological description of hearing loss and other otolaryngological manifestations reported by patients registered in the Hunter Outcome Survey (HOS), an international registry of patients with MPS II.Methods: Data about ear signs and symptoms were available for 554 of the 605 patients alive at HOS entry. The degree of hearing loss for 162 pure‐tone audiograms (PTAs) from 83 patients was classified by independent interpreters using both the age‐specific International Institute of Standardization (ISO) 7029 standard and the age‐independent World Health Organization (WHO) clinical guidelines. A linear regression analysis using cross‐sectional data was conducted to investigate the relationship between hearing loss and age.Results: The most prevalent otolaryngological manifestations and interventions reported were otitis (either acute otitis media or chronic otitis media [72%]), hearing loss (67%), insertion of ventilation tubes (50%), adenoidectomy (47%), and hearing aids (41%). According to the ISO standard, only one patient out of the 83 with audiogram data in HOS had normal hearing in both ears at all time points. According to the WHO classification, 16% had normal hearing; hearing loss was mild in 24%, moderate in 31%, severe in 22%, and profound in 7%. In the linear regression analysis, the hearing threshold in the cohort increased with age at an estimated rate of approximately 1 dB per year.Conclusions: Hearing impairment is common in MPS II. Early otolaryngological evaluation and intervention is recommended.
- 25 August 2011
- Published by Wiley in Journal of Inherited Metabolic Disease
- Vol. 35 (2) , 343-353
Hearing loss in patients with mucopolysaccharidosis II: Data from HOS – the Hunter Outcome Survey
Background: Subjectively reported hearing loss is a common feature of mucopolysaccharidosis II (MPS II, Hunter syndrome). This study provides an epidemiological description of hearing loss and other otolaryngological manifestations reported by patients registered in the Hunter Outcome Survey (HOS), an international registry of patients with MPS II.Methods: Data about ear signs and symptoms were available for 554 of the 605 patients alive at HOS entry. The degree of hearing loss for 162 pure‐tone audiograms (PTAs) from 83 patients was classified by independent interpreters using both the age‐specific International Institute of Standardization (ISO) 7029 standard and the age‐independent World Health Organization (WHO) clinical guidelines. A linear regression analysis using cross‐sectional data was conducted to investigate the relationship between hearing loss and age.Results: The most prevalent otolaryngological manifestations and interventions reported were otitis (either acute otitis media or chronic otitis media [72%]), hearing loss (67%), insertion of ventilation tubes (50%), adenoidectomy (47%), and hearing aids (41%). According to the ISO standard, only one patient out of the 83 with audiogram data in HOS had normal hearing in both ears at all time points. According to the WHO classification, 16% had normal hearing; hearing loss was mild in 24%, moderate in 31%, severe in 22%, and profound in 7%. In the linear regression analysis, the hearing threshold in the cohort increased with age at an estimated rate of approximately 1 dB per year.Conclusions: Hearing impairment is common in MPS II. Early otolaryngological evaluation and intervention is recommended.